Work Programme 2023 for the EU Initiative on Health Security, which works to set up a regional workforce responsible for the prevention and control of communicable diseases.
The December 2022 characterisation report, was the third report for the 2022-2023 influenza season. Currently, as of week 08/2023, 231 015 detections have been reported.
Between 3 December 2022 and 1 March 2023 highly pathogenic avian influenza (HPAI) A(H5N1) virus, clade 2.3.4.4b, was reported in Europe in domestic (522) and wild (1,138) birds over 24 countries. An unexpected number of HPAI virus detections in sea birds were observed, mainly in gull species and particularly in black-headed gulls (large mortality events were observed in France, Belgium, the Netherlands, and Italy).
Between 31 December and 5 January, 59 pneumonia cases possibly associated with a novel coronavirus have been reported in Wuhan, China with a common exposure link to Wuhan’s South China Seafood City market.
The European Region was declared polio-free in 2002. Since then, renewed circulation of wild poliovirus type 1 (WPV1) and outbreaks of circulating vaccine-derived poliovirus (cVDPV) has been observed globally.
This report describes and summarises the national results of the external quality assessment (EQA) of laboratory performance for those laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2021.
Since early May 2022 and as of 7 July, cases of monkeypox (MPX) have been reported in non-endemic countries. Twenty-six European Union/European Economic Area (EU/EEA) countries have reported 4 908 cases, representing 65% of all cases reported worldwide in 2022.
This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected between February and August 2022.
This is the seventh report for the 2019 2019–20 influenza season. As of week 20 / 16 4 868 influenza detections across the WHO European Region ha have been reported; 73% type A viruses, with A(H1N1)pdm09 prevailing over A(H3N2), and 27% type B viruses, with 4 4 479 (98%) of 4 5 568 ascribed to a lineage being B/Victoria.